3 weeks Zymeworks (NYSE:ZYME) Rating Lowered to “Equal Weight” at Wells Fargo & CompanyMarketBeat
Wells Fargo & Company cut Zymeworks from an “overweight” rating to an “equal weight” rating and set a $12.00 price objective for the company. in a report on Friday.
X